Back to mobile site

JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

February 26, 2025 10:00 AM EST Send to a Friend
JPMorgan analyst Chris Schott reiterated an Overweight rating and $1,100.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "As ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login